Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same

Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same

US Patent 6017733 · Granted Jan 25, 2000

Estimated economic value: $106,603,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified binding molecules comprising connecting peptides2013
Expression and use of anti-CD20 Antibodies2010
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2010
Recombinant anti-CD4 antibodies for human therapy2008
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2008
Anti-CD20 antibodies2008
Expression and use of anti-CD20 antibodies2008
Recombinant anti-CD4 antibodies for human therapy2008
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2008
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2007
γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics2006
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2005